09/2009 - Državni zavod za intelektualno vlasništvo
09/2009 - Državni zavod za intelektualno vlasništvo
09/2009 - Državni zavod za intelektualno vlasništvo
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
3560 HR - Patenti - Hrvatski glasnik <strong>intelektualno</strong>g vlasništva 16, 20<strong>09</strong>, 9, 3373 – 3601<br />
Podnositelj europske MKP Broj objave europske Naziv izuma<br />
prijave patenta<br />
prijave patenta<br />
(71) (51) (97) (54)<br />
Pipe Restoration Technologies, Inc., US B23P 6/00 (2006.01)<br />
EP 2<strong>09</strong>9581 * METHODS AND SYSTEMS FOR COATING AND<br />
B22D 19/10 (2006.01)<br />
SEALING INSIDE PIPING SYSTEMS<br />
B22D 1/00 (2006.01)<br />
B05D 7/22 (2006.01)<br />
PLEXXIKON, INC., US C07D 471/04 (2006.01)<br />
EP 2086972 * COMPOUNDS MODULATING C-FMS AND/OR C-KIT<br />
A61K 31/437 (2006.01)<br />
PLEXXIKON, INC., US C07D 471/04 (2006.01)<br />
A61K 31/437 (2006.01)<br />
A61P 25/00 (2006.01)<br />
A61P 29/00 (2006.01)<br />
A61P 35/00 (2006.01)<br />
PLEXXIKON, INC., US C07D 471/04 (2006.01)<br />
A61K 31/435 (2006.01)<br />
A61P 35/00 (2006.01)<br />
Polifoam Müanyagfeldolgozó Kft., HU F16L 11/24 (2006.01)<br />
Portola Pharmaceuticals, Inc., US A61K 31/536 (2006.01)<br />
A61K 31/517 (2006.01)<br />
A61K 31/381 (2006.01)<br />
C07D 239/96 (2006.01)<br />
C07D 265/22 (2006.01)<br />
C07D 403/12 (2006.01)<br />
C07D 4<strong>09</strong>/12 (2006.01)<br />
C07D 413/12 (2006.01)<br />
C07D 413/14 (2006.01)<br />
C07D 4<strong>09</strong>/14 (2006.01)<br />
C07D 417/14 (2006.01)<br />
A61P 7/02 (2006.01)<br />
PPG B.V., NL B63B 59/04 (2006.01)<br />
C<strong>09</strong>D 5/16 (2006.01)<br />
B05D 5/00 (2006.01)<br />
B05D 5/08 (2006.01)<br />
Praecis Pharmaceuticals Incorporated,<br />
US<br />
B05D 7/16 (2006.01)<br />
C07D 233/64 (2006.01)<br />
C07D 241/04 (2006.01)<br />
C07D 241/08 (2006.01)<br />
C07D 277/28 (2006.01)<br />
C07D 285/12 (2006.01)<br />
C07C 237/20 (2006.01)<br />
C07F 9/<strong>09</strong> (2006.01)<br />
A61K 31/426 (2006.01)<br />
A61K 31/433 (2006.01)<br />
A61K 31/661 (2006.01)<br />
A61K 31/167 (2006.01)<br />
A61P 25/28 (2006.01)<br />
Pronova BioPharma Norge AS, NO C07C 69/587 (2006.01)<br />
A61K 31/202 (2006.01)<br />
A61K 31/232 (2006.01)<br />
A61P 1/16 (2006.01)<br />
A61P 29/00 (2006.01)<br />
A61P 3/04 (2006.01)<br />
A61P 3/10 (2006.01)<br />
C07C 229/30 (2006.01)<br />
C07C 323/54 (2006.01)<br />
C07C 57/13 (2006.01)<br />
C07C 69/602 (2006.01)<br />
C07C 69/732 (2006.01)<br />
C07C 69/734 (2006.01)<br />
C11C 3/00 (2006.01)<br />
A61K 49/00 (2006.01)<br />
Prosurgics Limited, GB A61B 19/00 (2006.01)<br />
Protaffin Biotechnologie AG, AT G01N 33/50 (2006.01)<br />
G01N 33/569 (2006.01)<br />
Proyecto de Biomedicina Cima, S.L., ES C12N 15/86 (2006.01)<br />
QLT Plug Delivery, Inc., US A61F 2/14 (2006.01)<br />
A61M 31/00 (2006.01)<br />
A61M 35/00 (2006.01)<br />
A61B 18/18 (2006.01)<br />
Ratiopharm GmbH, DE A61K 9/14 (2006.01)<br />
A61K 9/20 (2006.01)<br />
A61K 31/34 (2006.01)<br />
A61K 31/343 (2006.01)<br />
Reliant Exams AS, NO G<strong>09</strong>B 7/00 (2006.01)<br />
Reliant Pharmaceuticals, Inc., US A61K 31/20 (2006.01)<br />
Reliant Pharmaceuticals, Inc., US A01N 37/00 (2006.01)<br />
A61K 31/20 (2006.01)<br />
EP 2<strong>09</strong>4701 *<br />
EP 2<strong>09</strong>7414 *<br />
EP 2100067 *<br />
EP 2<strong>09</strong>4272 *<br />
EP 2086827 *<br />
EP 2<strong>09</strong>9768 *<br />
EP 2<strong>09</strong>4640 *<br />
EP 2<strong>09</strong>7035 *<br />
EP 20897<strong>09</strong> *<br />
EP 2<strong>09</strong>7533 *<br />
EP 2<strong>09</strong>7044 *<br />
EP 20865<strong>09</strong> *<br />
EP 2100285 *<br />
EP 2089014 *<br />
EP 2<strong>09</strong>9295 *<br />
ACTIVITY AND USES THEREFOR<br />
COMPOUNDS AND METHODS FOR KINASE<br />
MODULATION, AND INDICATIONS THEREFOR<br />
PYRROLO [2, 3-B]PYRIDINE DERIVATIVES AS<br />
KINASE MODULATORS<br />
DUCT ELEMENT FOR AIR HANDLING SYSTEMS<br />
NITROGEN CONTAINING SUBSTITUTED<br />
HETEROCYCLES AS PLATELET ADP RECEPTOR<br />
INHIBITORS<br />
FOULING RELEASE NEW BUILDING COATING<br />
PROCESS<br />
AGONISTS OF THE SPHINGOSINE-1-PHOSPHATE<br />
RECEPTOR<br />
ALPHA-SUBSTITUTED OMEGA-3 LIPIDS THAT ARE<br />
ACTIVATORS OR MODULATORS OF THE<br />
PEROXISOME PROLIFERATORS-ACTIVATED<br />
RECEPTOR (PPAR).<br />
FIDUCIAL MARKER PLACEMENT<br />
SYSTEM TO ASSESS THE BIOLOGICAL ACTIVITY<br />
OF CHEMOATTRACTANTS<br />
VIRAL VECTOR AND USES THEREOF<br />
DRUG DELIVERY IMPLANTS FOR INHIBITION OF<br />
OPTICAL DEFECTS<br />
ESCITALOPRAM AND SOLID PHARMACEUTICAL<br />
COMPOSITION COMPRISING THE SAME<br />
SYSTEM AND METHOD FOR IMPROVING THE<br />
QUALITY OF COMPUTER GENERATED EXAMS<br />
OMEGA-3 FATTY ACIDS AND DYSLIPIDEMIC AGENT<br />
FOR REDUCTION OF APO-B LEVELS<br />
PROPHLYAXIS AND TREATMENT OF ATRIAL<br />
FIBRILLATION WITH OMEGA-3 FATTY ACIDS<br />
ISSN 1331-2030